The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical actionability of germline testing in patients with limited colorectal polyps.
 
Mersedeh Rohanizadegan
No Relationships to Disclose
 
Saud H Aldubayan
No Relationships to Disclose
 
Marios Giannakis
No Relationships to Disclose
 
Xinmeng Jasmine Mu
No Relationships to Disclose
 
Reiko Nishihara
No Relationships to Disclose
 
Zhi Rong Qian
No Relationships to Disclose
 
Jonathan Nowak
No Relationships to Disclose
 
Yin Cao
No Relationships to Disclose
 
Li Liu
No Relationships to Disclose
 
Mingyang Song
No Relationships to Disclose
 
Andrew T. Chan
Consulting or Advisory Role - Aralez Pharmaceuticals; Bayer Schering Pharma; Pfizer
 
Levi A. Garraway
Employment - Lilly
Stock and Other Ownership Interests - Foundation Medicine
Honoraria - Bayer
Consulting or Advisory Role - Boehringer Ingelheim; Foundation Medicine; Novartis; Third Rock Ventures; Warp Drive Bio
Research Funding - Astellas Pharma; GlaxoSmithKline; Novartis
Travel, Accommodations, Expenses - Bayer; Novartis; Wuxi AppTec
 
Shuji Ogino
No Relationships to Disclose
 
Charles S. Fuchs
Consulting or Advisory Role - Agios; Bayer; Dicerna; Entrinsic Health; Five Prime Therapeutics; Genentech/Roche; Gilead Sciences; KEW; Lilly; Merck; Merrimack; Sanofi; Taiho Pharmaceutical
 
Eliezer Mendel Van Allen
Stock and Other Ownership Interests - Syapse
Consulting or Advisory Role - Genome Medical; Novartis; Roche; Syapse; Takeda; Third Rock Ventures
Research Funding - Bristol-Myers Squibb; Novartis